Mr. Broussard sold 18,000 shares at a free market value of $328.66, according to the filing.
Humana recently posted better-than-expected earnings, reporting revenues of $14.3 billion in the second quarter of 2018, up 5.4 percent from $13.5 billion reported in the same period a year prior. Humana said the change largely reflected gains in its Medicare Advantage business, as well as in its group and specialty segments.
More articles on payers:
Vermont board won’t weigh in on CEO compensation after exec pay freeze urged
1-year pay freeze urged for Vermont hospitals execs making more than $500K
The 4 best-paying healthcare jobs for women
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
